Page 1336 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Chapter 95Kaye E. Hale

REFERENCES

1. Hausmann OV, Seitz M, Villiger PM, Pichler WJ. The complex 14. Hartmann LC, Tschetter LK, Habermann TM, et al. Granulocyte
clinical picture of side effects to biologicals. Med Clin North Am. colony-stimulating factor in severe chemotherapy-induced
July 2010;94(4):791-804, xi-xii. afebrile neutropenia. N Engl J Med. June 19, 1997;336(25):
2. Baquiran D. Lippincott’s Cancer Chemotherapy Handbook. 2nd 1776-1780.
ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. 15. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice
3. Chabner B, Amrein P, Drucker B, et al. Antineoplastic agents. guideline for the use of antimicrobial agents in neutropenic
In: Brunton L, Lazo J, Parker K, eds. Goodman & Gilman’s The patients with cancer: 2010 update by the infectious diseases
Pharmacologic Basis of Therapeutics. 11the ed. The McGraw- society of america. Clin Infect Dis. February 2011;52(4):e56-e93.
Hill Companies, Inc; 2006. 16. Vahid B, Marik PE. Pulmonary complications of novel antineo-
4. Daniel D, Crawford J. Myelotoxicity from chemotherapy. Semin plastic agents for solid tumors. Chest. February 2008;133(2):
Oncol. February 2006;33(1):74-85. 528-538.
5. Murphy MF, Wallington TB, Kelsey P, et al. Guidelines for the 17. Al Ameri A, Koller C, Kantarjian H, et al. Acute pulmonary
clinical use of red cell transfusions. Br J Haematol. April 2001; failure during remission induction chemotherapy in adults with
113(1):24-31. acute myeloid leukemia or high-risk myelodysplastic syndrome.
6. Spiess BD. Red cell transfusions and guidelines: a work in Cancer. January 1, 2010;116(1):93-97.
progress. Hematol Oncol Clin North Am. 2007;21(1):185-200. 18. Haupt HM, Hutchins GM, Moore GW. Ara-C lung: noncar-
diogenic pulmonary edema complicating cytosine arabinoside
7. Ram R, Bonstein L, Gafter-Gvili A, Ben-Bassat I, Shpilberg therapy of leukemia. Am J Med. February 1981;70(2):256-261.
O, Raanani P. Rituximab-associated acute thrombocytopenia:
an under-diagnosed phenomenon. Am J Hematol. April 2009; 19. Kopterides P, Lignos M, Mentzelopoulos S, Armaganidis
84(4):247-250. A, Pappa V. Cytarabine-induced lung injury: case report.
Anticancer Drugs. August 2005;16(7):743-745.
8. Apelseth TO, Hervig T, Bruserud Ø. Current practice and future
directions for optimization of platelet transfusions in patients 20. Briasoulis E, Pavlidis N. Noncardiogenic pulmonary edema:
with severe therapy-induced cytopenia. Blood Rev. May 2011; an unusual and serious complication of anticancer therapy.
25(3):113-122. Oncologist. 2001;6(2):153-161.
9. Stanworth SJ, Hyde C, Heddle N, Rebulla P, Brunskill S, Murphy 21. Meadors M, Floyd J, Perry MC. Pulmonary toxicity of chemo-
MF. Prophylactic platelet transfusion for haemorrhage after therapy. Semin Oncol. February 2006;33(1):98-105.
chemotherapy and stem cell transplantation. Cochrane Database 22. Tallman MS, Andersen JW, Schiffer CA, et al. Clinical descrip-
Syst Rev 2004(4):CD004269. tion of 44 patients with acute promyelocytic leukemia who
developed the retinoic acid syndrome. Blood. January 1, 2000;
10. Schiffer CA, Anderson KC, Bennett CL, et al. Platelet transfu- 95(1):90-95.
sion for patients with cancer: clinical practice guidelines of the
American Society of Clinical Oncology. J Clin Oncol. March 1, 23. Patatanian E, Thompson DF. Retinoic acid syndrome: a review.
2001;19(5):1519-1538. J Clin Pharm Ther. August 2008;33(4):331-338.
11. Crawford J, Dale DC, Lyman GH. Chemotherapy-induced 24. Lee-Chiong T Jr, Matthay RA. Drug-induced pulmonary edema
neutropenia: risks, consequences, and new directions for its and acute respiratory distress syndrome. Clin Chest Med. March
management. Cancer. January 15, 2004;100(2):228-237. 2004;25(1):95-104.
12. Wolach O, Bairey O, Lahav M. Late-onset neutropenia after 25. Jung JI, Choi JE, Hahn ST, Min CK, Kim CC, Park SH.
rituximab treatment: case series and comprehensive review Radiologic features of all-trans-retinoic acid syndrome. AJR Am
of the literature. Medicine (Baltimore). September 2010; J Roentgenol. February 2002;178(2):475-480.
89(5):308-318. 26. Sleijfer S. Bleomycin-induced pneumonitis. Chest. August
13. Lyman GH, Kleiner JM. Summary and comparison of myeloid 2001;120(2):617-624.
growth factor guidelines in patients receiving cancer chemo- 27. Luis M, Ayuso A, Martinez G, Souto M, Ortells J. Intraoperative
therapy. Cancer Treat Res. 2011;157:145-165. respiratory failure in a patient after treatment with bleomycin:

Section07-O-ref.indd 1 1/21/2015 11:26:52 AM